Numares: Gregory Heath

Numares has appointed Gregory Heath as a member of its supervisory board. Heath will assist Numares in the commercialization of multi-marker-based diagnostic tests running on the company's proprietary, AI-driven IVD platform, the AXINON System, for which the company applied for two 510(k) clearances this year. Heath has more than 30 years of diagnostics experience, including as a former general manager of diagnostics at Illumina. Prior to this he was SVP of the molecular business at Roche Diagnostics. He currently serves on the scientific advisory board of Everlywell.